Stem cell reports

PTC124 may help restore protein production in lab-grown retinal tissue for AIPL1-related Leber congenital amaurosis

Updated

Abstract

Retinal organoids derived from children with AIPL1 mutations exhibited undetectable AIPL1 levels and increased cGMP.

  • AIPL1 mutations lead to severe vision impairment and rapid photoreceptor degeneration in Leber congenital amaurosis type 4 (LCA4).
  • Photoreceptors generated from induced pluripotent stem cells (iPSCs) displayed molecular characteristics consistent with LCA4.
  • The translational drug PTC124 showed low efficacy in rescuing full-length AIPL1 in retinal organoids.
  • Full restoration of phosphodiesterase 6 (PDE6) activity in photoreceptors and reduction of cGMP levels were not achieved.
  • LCA4 retinal organoids serve as a useful model for testing new therapeutic approaches.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of interest The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free